Bionano Q3 revenue $7.4M (+21% YoY); raises FY 2025 OGM install guidance

Bionano Genomics, Inc.

2025-Q3 EPS reported -$4.82 vs consensus -$1.95 ▼ miss (-147.4%)

Total revenue $7.4M, up 21% from $6.1M in Q3 2024; consumables/software revenue +15%.
GAAP gross margin 46% vs (139)% a year ago; non-GAAP gross margin 46% vs 26%.
Operating expenses cut 66% to $11.9M; cash and investments $31.8M at quarter-end.
Raised FY 2025 OGM system install guidance to >25 units (prior 20-25).
Reiterated FY 2025 revenue guidance $26-30M; Q4 2025 revenue guided $7.5-7.9M.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.